Peroral delivery of insulin using chitosan derivatives: A comparative study of polyelectrolyte nanocomplexes and nanoparticles

被引:115
作者
Jintapattanakit, Anchalee
Junyaprasert, Varaporn B.
Mao, Shirui
Sitterberg, Johannes
Bakowsky, Udo
Kissel, Thomas
机构
[1] Univ Marburg, Dept Pharmaceut & Biopharm, D-35032 Marburg, Germany
[2] Mahidol Univ, Fac Pharm, Dept Pharm, Bangkok 10400, Thailand
[3] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Peoples R China
关键词
PEGylated trimethyl chitosan; polyelectrolyte complexes; nanoparticles; insulin; peroral delivery;
D O I
10.1016/j.ijpharm.2007.05.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Polymeric delivery systems based on nanoparticles (NP) have emerged as a promising approach for peroral insulin delivery. Using a trimethyl chitosan (TMC) and a PEG-graft-TMC copolymer, polyelectrolyte complexes (PEC) and nanoparticles were prepared and their properties were compared. The amount of insulin was quantified by HPLC and the stability of PEC and NP upon exposure to simulated gastrointestinal (GI) fluid was monitored by dynamic laser light scattering. It was shown that polymer/insulin (+/-) charge ratio played an important role in PEC and NP formation. Stable, uniform, and spherical PEC/NP with high insulin association efficiency (AE) were formed at or close to optimized polymer/insulin (+/-) charge ratio, depending on polymer structure. All PEC were more stable in pH 6.8 simulated intestinal fluid (SIF) than NP. The PEC also appeared to play some role in protecting insulin from degradation at higher temperature and with proteolytic enzyme more efficiently than NP. On the basis of these results, polyelectrolyte complexation can be suggested as a potentially useful technique for generating insulin delivery systems for peroral administration. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:240 / 249
页数:10
相关论文
共 53 条
  • [1] Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: Complexation and stabilization of insulin
    Akiyoshi, K
    Kobayashi, S
    Shichibe, S
    Mix, D
    Baudys, M
    Kim, SW
    Sunamoto, J
    [J]. JOURNAL OF CONTROLLED RELEASE, 1998, 54 (03) : 313 - 320
  • [2] Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications
    Berger, J
    Reist, M
    Mayer, JM
    Felt, O
    Gurny, R
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (01) : 35 - 52
  • [3] BERNKOPSCHNURCH A, 2006, INT J PHARM, V62, P267
  • [4] Chitosan drug binding by ionic interaction
    Boonsongrit, Y
    Mitrevej, A
    Mueller, BW
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 62 (03) : 267 - 274
  • [5] BRANGE J, 1992, ACTA PHARM NORDICA, V4, P149
  • [6] Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO
  • [7] 2-4
  • [8] Nanosphere based oral insulin delivery
    Carino, GP
    Jacob, JS
    Mathiowitz, E
    [J]. JOURNAL OF CONTROLLED RELEASE, 2000, 65 (1-2) : 261 - 269
  • [9] DAMAGE C, 1997, J PHARM PHARMACOL, V49, P949
  • [10] Nasal delivery of insulin using novel chitosan based formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles
    Dyer, AM
    Hinchcliffe, M
    Watts, P
    Castile, J
    Jabbal-Gill, I
    Nankervis, R
    Smith, A
    Illum, L
    [J]. PHARMACEUTICAL RESEARCH, 2002, 19 (07) : 998 - 1008